Interestingly, the succinate receptor (GPR91) expression was increased in patients with coronary artery disease and diabetes, and the authors showed that antagonising GPR91 signalling offers a promising therapeutic strategy [169]. The gene discussed is SUCNR1; the disease is diabetes mellitus.